Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 1,008 | 1,828 | 512 | 2,501 | 418 |
| Gross Profit | 1,008 | 1,828 | 512 | 2,501 | 418 |
| Operating Expenses | 73,634 | 63,246 | 60,418 | 60,179 | 37,103 |
| Operating Income | -72,626 | -61,418 | -59,906 | -57,678 | -36,685 |
| Other Income | 3,670 | 3,102 | 2,447 | 1,690 | 767 |
| Pre-tax Income | -68,956 | -58,316 | -57,459 | -55,988 | -35,918 |
| Net Income Continuous | -66,944 | -60,177 | -62,554 | -55,979 | -37,648 |
| Net Income | $-66,944 | $-60,177 | $-62,554 | $-55,979 | $-37,648 |
| EPS Basic Total Ops | -0.94 | -0.85 | -0.94 | -0.83 | -0.61 |
| EPS Basic Continuous Ops | -0.94 | -0.85 | -0.94 | -0.83 | -0.61 |
| EPS Diluted Total Ops | -0.94 | -0.85 | -0.94 | -0.83 | -0.61 |
| EPS Diluted Continuous Ops | -0.94 | -0.85 | -0.94 | -0.83 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.94 | -0.85 | -0.90 | -0.83 | -0.61 |
| EBITDA(a) | $-72,034 | $-61,497 | $-59,339 | $-56,536 | $-35,120 |